1 Division of Head and Neck Surgery and Communication Sciences, Duke University Medical Center, Durham, North Carolina, USA.
2 Department of Otolaryngology, George Washington University, Washington, DC, USA.
Otolaryngol Head Neck Surg. 2018 Jul;159(1):42-50. doi: 10.1177/0194599818764387. Epub 2018 Mar 20.
Objective To evaluate the prevalence of migraine disease in an otolaryngologic cohort and migraine-related otologic and sinonasal symptoms in this population. Study Design Cross-sectional study utilizing the CHEER (Creating Healthcare Excellence through Education and Research) network for recruitment. Setting Patients were recruited in a cross-sectional and pragmatic manner in 14 CHEER sites between June 2015 and March 2017 (9 academic, 5 community based). Subjects and Methods Patients were included if they were aged ≥18 years and seen for any concern that was not head and neck cancer. Patients with any history of brain abnormality or headaches that began within 2 weeks of a medical illness, trauma, or head injury were excluded. Patients were screened for migraine with a validated instrument. If they screened positive on the Migraine Assessment Tool (MAT+), the subjects also filled out validated and custom questionnaires for sinonasal, otologic, and migraine-specific symptoms. Results Of 1458 patients screened, 235 (16.1%) screened positive for migraine (MAT+), which is higher than general population (13%, P < .001). The MAT+ group was significantly younger (47.2 vs 55.6 years of age, P < .001) and predominantly women (80.0% vs 55.9%, P < .001). The MAT+ cohort commonly reported ear- and sinus-related symptoms, such as tinnitus (70.5%), ear pressure (61.9%), balance problems (82%), facial pressure (85%), and rhinorrhea (49.9%). There were significantly higher levels of sinus burden with higher levels of dizziness handicap, Jonckheere-Terpstra test = 11,573.00, z = 7.471, P < .001. Conclusion Migraine disease has a higher prevalence in an otolaryngologic cohort than in the general population, presenting with a high rate of sinonasal and otologic symptoms that may be due to or exacerbated by migraines.
评估耳鼻喉科队列中偏头痛疾病的患病率,以及该人群中与偏头痛相关的耳科和鼻-鼻窦症状。
利用 CHEER(通过教育和研究创造医疗卓越)网络进行招募的横断面研究。
于 2015 年 6 月至 2017 年 3 月在 14 个 CHEER 站点以横断面和实用方式招募患者(9 个学术性,5 个社区性)。
如果患者年龄≥18 岁且因任何非头颈部癌症相关问题就诊,则纳入研究。如果患者有任何脑异常病史或头痛史,且头痛始于医疗疾病、创伤或头部外伤后 2 周内,则将其排除。使用经过验证的工具对患者进行偏头痛筛查。如果他们在偏头痛评估工具(MAT+)上呈阳性,则这些患者还需填写经过验证的和定制的鼻-鼻窦、耳科和偏头痛特异性症状问卷。
在筛查的 1458 名患者中,235 名(16.1%)筛查出偏头痛(MAT+)阳性,高于一般人群(13%,P<.001)。MAT+组的年龄显著更小(47.2 岁 vs 55.6 岁,P<.001),且主要为女性(80.0% vs 55.9%,P<.001)。MAT+队列常报告与耳和鼻窦相关的症状,如耳鸣(70.5%)、耳压(61.9%)、平衡问题(82%)、面部压力(85%)和鼻漏(49.9%)。头晕残障程度越高,鼻窦负担越重,Jonckheere-Terpstra 检验=11,573.00,z=7.471,P<.001。
与一般人群相比,偏头痛疾病在耳鼻喉科队列中的患病率更高,表现出较高的鼻-鼻窦和耳科症状发生率,这些症状可能是由偏头痛引起或加重的。